Sorin Avram

795 total citations
43 papers, 555 citations indexed

About

Sorin Avram is a scholar working on Computational Theory and Mathematics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Sorin Avram has authored 43 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Computational Theory and Mathematics, 22 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in Sorin Avram's work include Computational Drug Discovery Methods (23 papers), Protein Structure and Dynamics (8 papers) and Synthesis and biological activity (7 papers). Sorin Avram is often cited by papers focused on Computational Drug Discovery Methods (23 papers), Protein Structure and Dynamics (8 papers) and Synthesis and biological activity (7 papers). Sorin Avram collaborates with scholars based in Romania, United States and Denmark. Sorin Avram's co-authors include Alina Bora, Ramona Curpăn, Liliana Halip, Tudor I. Oprea, Ludovic Kurunczi, Liliana Păcureanu, Cristian Bologa, Luminita Crisan, Simona Funar‐Timofei and Jeffrey Knockel and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Sorin Avram

42 papers receiving 548 citations

Peers

Sorin Avram

CTM

PHARM

ONCOL

Ibrahim Damilare Boyenle Nigeria

Jianlong Peng China

Mukhtar Oluwaseun Idris China

Pradeep Anand Ravindranath United States

Sanna Niinivehmas Finland

Ákos Tarcsay Hungary

T. Ngoc Han Pham Vietnam

María Gálvez-Llompart Spain

Nathalie Lagarde France

Christophe Bovigny Switzerland

Ibrahim Damilare Boyenle Nigeria

Sorin Avram

261 ×0.8

185 ×0.6

CTM

116 ×1.0

40 ×0.7

PHARM

48 ×1.1

ONCOL

Citations per year, relative to Sorin Avram Sorin Avram (= 1×) peers Ibrahim Damilare Boyenle

Countries citing papers authored by Sorin Avram

Since Specialization

Citations

This map shows the geographic impact of Sorin Avram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sorin Avram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sorin Avram more than expected).

Fields of papers citing papers by Sorin Avram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sorin Avram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sorin Avram. The network helps show where Sorin Avram may publish in the future.

Co-authorship network of co-authors of Sorin Avram

This figure shows the co-authorship network connecting the top 25 collaborators of Sorin Avram. A scholar is included among the top collaborators of Sorin Avram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sorin Avram. Sorin Avram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oprea, Tudor I., Cristian Bologa, Jayme Holmes, et al.. (2024). Overview of the Knowledge Management Center for Illuminating the Druggable Genome. Drug Discovery Today. 29(3). 103882–103882. 5 indexed citations

Steinkamp, Ralph, Barbara Brauner, Corinna Montrone, et al.. (2024). CORUM in 2024: protein complexes as drug targets. Nucleic Acids Research. 53(D1). D651–D657. 1 indexed citations

Halip, Liliana, Sorin Avram, Ramona Curpăn, et al.. (2023). Exploring DrugCentral: from molecular structures to clinical effects. Journal of Computer-Aided Molecular Design. 37(12). 681–694. 4 indexed citations

Avram, Sorin, Liliana Halip, Ramona Curpăn, & Tudor I. Oprea. (2022). Novel drug targets in 2021. Nature Reviews Drug Discovery. 21(5). 328–328. 9 indexed citations

Halip, Liliana, et al.. (2021). Structure- and ligand- based studies to gain insight into the pharmacological implications of histamine H3 receptor. Structural Chemistry. 32(3). 1141–1149. 2 indexed citations

Avram, Sorin, et al.. (2021). Large-scale comparison between the diffraction-component precision indexes favors Cruickshank’s Rfree function. Journal of the Serbian Chemical Society. 87(3). 321–330. 1 indexed citations

Crisan, Luminita, Sorin Avram, Ludovic Kurunczi, & Liliana Păcureanu. (2020). Partial Least Squares Discriminant Analysis and 3D Similarity Perspective Applied to Analyze Comprehensively the Selectivity of Glycogen Synthase Kinase 3 Inhibitors. Molecular Informatics. 39(6). e1900142–e1900142. 1 indexed citations

Avram, Sorin, et al.. (2020). Evaluation of the cytotoxic and anti-angiogenic potential of flavone apigenin using the B164A5 mouse melanoma cell line. 26(3). 288–295. 1 indexed citations

Mioc, Marius, Sorin Avram, Ludovic Kurunczi, et al.. (2018). Design, Synthesis and Biological Activity Evaluation of S-Substituted 1H-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal Cancer. Frontiers in Chemistry. 6. 373–373. 30 indexed citations

10.

Avram, Sorin, et al.. (2018). Enhancing Molecular Promiscuity Evaluation Through Assay Profiles. Pharmaceutical Research. 35(11). 240–240. 3 indexed citations

11.

Avram, Sorin, Alina Bora, Liliana Halip, & Ramona Curpăn. (2018). Modeling Kinase Inhibition Using Highly Confident Data Sets. Journal of Chemical Information and Modeling. 58(5). 957–967. 18 indexed citations

12.

Mioc, Marius, Codruţa Şoica, Sorin Avram, et al.. (2017). Design, synthesis and pharmaco-toxicological assessment of 5-mercapto-1,2,4-triazole derivatives with antibacterial and antiproliferative activity. International Journal of Oncology. 50(4). 1175–1183. 27 indexed citations

13.

Crisan, Luminita, Sorin Avram, & Liliana Păcureanu. (2017). Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors. Molecular Diversity. 21(2). 385–405. 16 indexed citations

14.

Mioc, Marius, et al.. (2017). Docking Study of 3-mercapto-1,2,4-triazole Derivatives as Inhibitors for VEGFR and EGFR. Revista de Chimie. 68(3). 500–503. 7 indexed citations

15.

Curpăn, Ramona, Sorin Avram, Robert Vianello, & Cristian Bologa. (2014). Exploring the biological promiscuity of high-throughput screening hits through DFT calculations. Bioorganic & Medicinal Chemistry. 22(8). 2461–2468. 14 indexed citations

16.

Avram, Sorin, et al.. (2014). Quantitative estimation of pesticide-likeness for agrochemical discovery. Journal of Cheminformatics. 6(1). 42–42. 79 indexed citations

17.

Avram, Sorin, Luminita Crisan, Alina Bora, et al.. (2013). Retrospective group fusion similarity search based on eROCE evaluation metric. Bioorganic & Medicinal Chemistry. 21(5). 1268–1278. 12 indexed citations

18.

Goodarzi, Mohammad, et al.. (2013). Modeling of 2-Pyridin-3-yl-Benzo[d][1,3]Oxazin-4-one Derivatives by Several Conformational Searching Tools and Molecular Docking. Current Pharmaceutical Design. 19(12). 2194–2203. 5 indexed citations

19.

Crisan, Luminita, Liliana Păcureanu, Alina Bora, et al.. (2012). QSAR study and molecular docking on indirubin inhibitors of Glycogen Synthase Kinase-3. SHILAP Revista de lepidopterología. 11(1). 63–77. 12 indexed citations

20.

Avram, Sorin, et al.. (2005). Computer-Aided Drug Design for Typical and Atypical Antipsychotic Drugs: A Review of Application of QSAR and Combinatorial Chemistry Methods - Tools for New Antipsychotics Design. Current Computer - Aided Drug Design. 1(4). 347–364. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact